Obstructive Sleep Apnea in Women

Authors

  • Atul Khullar, MD, MSc, FRCPC, DABPN (Cert sleep medicine), DABOM, FAASM Department of Psychiatry, University of Alberta, Edmonton, AB
  • Jennifer Swainson, MD, FRCPC, DABOM Department of Psychiatry, University of Alberta, Edmonton, AB

DOI:

https://doi.org/10.58931/cwht.2024.1316

Abstract

Obstructive sleep apnea (OSA) is a common disease with a large public health burden. Due to several anatomical and physiological differences, OSA has traditionally thought to be much less common in women than in men. These differences include variations in craniofacial anatomy, sex hormone differences, greater peripheral fat distribution, as well as women having shorter and less collapsible airways and less respiratory drive instability. However the recruitment bias from clinical samples in early studies has fostered this sex difference to an exaggerated degree.

One large community-based sample of adults aged 21–80 indicated a point prevalence of OSA with clinically significant sleepiness of 3–7% in males and 2–5% of females. Another much larger worldwide community study indicated a lifetime prevalence of OSA of 27.3% in men and 22.5% in women in a narrower population aged 30–69. Both studies show an approximate 1:5–1 ratio which is much lower than that of previous studies showing a ratio of 9 or 10:1. In pediatric and elderly populations, the male to female prevalence ratio is close to equal.

Author Biographies

Atul Khullar, MD, MSc, FRCPC, DABPN (Cert sleep medicine), DABOM, FAASM, Department of Psychiatry, University of Alberta, Edmonton, AB

Dr. Atul Khullar is a psychiatrist and sleep specialist who focuses on the integrative management of obesity, sleep, mood/anxiety, and attention deficit disorders in age groups from adolescence onwards. He is a Clinical Associate Professor at the University of Alberta and the medical director of the Northern Alberta Sleep Clinic.

Jennifer Swainson, MD, FRCPC, DABOM, Department of Psychiatry, University of Alberta, Edmonton, AB

Dr. Jennifer Swainson is an associate clinical professor at the University of Alberta and a psychiatrist with expertise in treating difficult mood disorders and their comorbidities. She is a co-author of the Canadian Network for Mood and Anxiety Disorders (CANMAT) 2023 treatment guidelines for depression and is certified in Obesity Medicine. Dr. Swainson has an interest in the reciprocal relationships between mood disorders, sleep, and obesity and their subsequent treatment considerations.

References

Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. The Lancet. Respiratory medicine. 2019;7(8):687-98.

Bonsignore MR, Saaresranta T, Riha RL. Sex differences in obstructive sleep apnoea. Eur Respir Rev. 2019; 28(154): 190030.

Fietze I, Laharnar N, Obst A, et al. Prevalence and association analysis of obstructive sleep apnea with gender and age differences - Results of SHIP-Trend. J Sleep Res. 2019;28(5):e12770.

Lin CM, Davidson TM, Ancoli-Israel S. Gender differences in obstructive sleep apnea and treatment implications. Sleep Med Rev. 2008;12:481-96.

Quintana-Gallego E, Carmona-Bernal C, Capote F, et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med. 2004;98(10):984-9.

Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep. 2005;28(3):309-14.

Valipour A, Lothaller H, Rauscher H, et al. Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the sleep disorders questionnaire. Sleep. 2007;30(3):312-19.

Wimms A, Woehrle H, Ketheeswaran S, et al. Obstructive sleep apnea in women: specific issues and interventions. BioMed Res Int. 2016:1764837.

Lindberg E, Benediktsdottir B, Franklin KA, et al. Women with symptoms of sleep-disordered breathing are less likely to be diagnosed and treated for sleep apnea than men. Sleep Med. 2017;35:17-22.

Martins FO, Conde SV. Gender differences in the context of obstructive sleep apnea and metabolic diseases. Front Physiol. 2021;12:792633.

Schiza SE, Bouloukaki I. Does gender matter: sex-specific aspects of symptoms, outcome, and therapy of obstructive sleep apnea. Current Opinion in Pulmonary Medicine. 2020; 26(6):642-9.

Macey PM, Woo MA, Kumar R, et al. Relationship between obstructive sleep apnea severity and sleep, depression and anxiety symptoms in newly-diagnosed patients. PloS one. 2010;5(4):e10211.

Forcelini CM, Buligon CM, Costa GJK, et al. Age-dependent influence of gender on symptoms of obstructive sleep apnea in adults. Sleep Sci. 2019 Jul-Sep;12(3):132-7.

Lee W, Lee SA, Ryu HU, et al. Quality of life in patients with obstructive sleep apnea: Relationship with daytime sleepiness, sleep quality, depression, and apnea severity. Chron Respir Dis. 2016 Feb;13(1):33-9.

Tasbakan MS, Gunduz C, Pirildar S, et al. Quality of life in obstructive sleep apnea is related to female gender and comorbid insomnia. Sleep Breath. 2018;22(4):1013-20.

Basoglu OK, Tasbakan MS. Gender differences in clinical and polysomnographic features of obstructive sleep apnea: a clinical study of 2827 patients. Sleep Breath. 2018;22(1): 241-9.

Ljunggren M, Naessén T, Theorell-Haglöw J, et al. Rapid eye movement sleep apnea and carotid intima thickness in men and women: a SHE-MUSTACHE cohort study. J Sleep Res. 2022 Oct;31(5):e13599

Bouloukaki I, Tsiligianni I, Schiza S. Evaluation of obstructive sleep apnea in female patients in primary care: time for improvement? Med Princ Pract. 2021;30(6):508-14.

Liu L, Su G, Wang S, et al. The prevalence of obstructive sleep apnea and its association with pregnancy-related health outcomes: a systematic review and meta-analysis. Sleep Breath. 2019;23(2):399-412.

Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17).

Erickson TS, Durr ML. Sex differences in obstructive sleep apnea including pregnancy and response to treatment. Otolaryngol Clin North Am. 2024;57(3):467-80.

Maniaci A, La Via L, Pecorino B, et al. Obstructive sleep apnea in pregnancy: a comprehensive review of maternal and fetal implications. Neurol Int. 2024;16(3), 522-32.

Dominguez JE, Krystal AD, Habib AS. Obstructive sleep Apnea in pregnant women: a review of pregnancy outcomes and an approach to management. Anes analg. 2018;127(5):1167-77.

Louis JM, Mogos MF, Salemi JL, et al. Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998-2009. Sleep. 2014;37(5):843-9.

Li L, Zhao K, Hua J, et al. Association between sleep-disordered breathing during pregnancy and maternal and fetal outcomes: an updated systematic review and meta-analysis. Front Neurol. 2018;9:91.

Chen YH, Kang JH, Lin CC, et al. Obstructive sleep apnea and the risk of adverse pregnancy outcomes. AJOG. 2012;206(2):136.e1–136.e1365.

Bourjeily G, Danilack VA, Bublitz MH, et al. Maternal obstructive sleep apnea and neonatal birth outcomes in a population based sample. Sleep Med. 2020;66:233-40.

Nugent R, Wee A, Kearney L, et al. The effectiveness of continuous positive airway pressure for treating obstructive sleep apnoea in pregnancy: A systematic review. Aust N Z J Obstet Gynaecol. 2023;63(3):290-300.

Rasquin LI, Anastasopoulou C, Mayrin JV. Polycystic ovarian disease. [Updated 2022 Nov 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459251/

Kahal H, Kyrou I, Uthman OA, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep Breath. 2020;24(1):339-50.

Kahal K, Kyrou I, Uthman O, et al. The association between obstructive sleep apnea and metabolic abnormalities in women with polycystic ovary syndrome: a systematic review and meta-analysis. Sleep. 2018;41(7):10.1093/sleep/zsy085.

Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care. 2003;167(9):1181-5.

Mirer AG, Young T, Palta M, et al. Sleep-disordered breathing and the menopausal transition among participants in the Sleep in Midlife Women Study. Menopause. 2017;24(2):157-62.

Huang T, Lin BM, Redline S, et al. Type of menopause, age at menopause, and risk of developing obstructive sleep apnea in postmenopausal women. Am J Epidemiol. 2008;187(7):1370-9.

Perger E, Mattaliano P, Lombardi C. Menopause and Sleep Apnea. Maturitas. 2019;124: 35-8.

Mou J, Pflugeisen BM, Crick BA, et al. The discriminative power of STOP-Bang as a screening tool for suspected obstructive sleep apnea in clinically referred patients: considering gender differences. Sleep Breath 2019;23(1):65-75.

Pataka A, Kotoulas S, Kalamaras G, et al. Gender differences in obstructive sleep apnea: the value of sleep questionnaires with a separate analysis of cardiovascular patients. J Clin Med. 2020; 9(1):130.

Facco FL, Ouyang DW, Zee PC. Sleep disordered breathing in a high-risk cohort prevalence and severity across pregnancy. Am J Perinatol. 2014;31(10):899-904.

Sommerfeldt J, Duffy A, Blanco C, et al. Factors affecting polysomnography compliance and delays to surgical treatment of obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2023:171: 111637.

Farid S, Giunio-Zorkin M, Schust DJ. Obstructive sleep apnea in pregnancy: A review of the literature from the obstetrics practitioner’s view and a proposed clinical approach. EJOG. 2024;300: 29-34.

https://www.thoracic.org/statements/resources/sleep-medicine/mild-osa-exec-summ.pdf

Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, Sands SA, Schwab RJ, Dunn JP, Chakladar S, Bunck MC, Bednarik J; SURMOUNT-OSA Investigators. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024 Jun 21. doi: 10.1056/NEJMoa2404881. Epub ahead of print. PMID: 38912654.

Blackman A, Foster GD, Zammit G, Rosenberg R, Aronne L, Wadden T, Claudius B, Jensen CB, Mignot E. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016 Aug;40(8):1310-9. doi: 10.1038/ijo.2016.52. Epub 2016 Mar 23. PMID: 27005405; PMCID: PMC4973216

Newman AB, Foster G, Givelber R, et al. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med. 2005; 165(20):2408–13

Patel SR, Bakker JP, Stitt CJ, et al. Age and sex disparities in adherence to CPAP. Chest. 2021 Jan;159(1):382-9.

Vecchierini MF, Attali V, Collet JM; ORCADES Investigators; Abedipour, D, Allard-Redon A, Aranda A, et al. Sex differences in mandibular repositioning device therapy effectiveness in patients with obstructive sleep apnea syndrome. Sleep Breath; 2019;23(3):837-48.

Downloads

Published

2024-11-11

How to Cite

Khullar, A., & Swainson, J. (2024). Obstructive Sleep Apnea in Women. Canadian Women’s Health Today, 1(3), 12–19. https://doi.org/10.58931/cwht.2024.1316

Issue

Section

Articles